i am a medical scientist and have backed msb, along with occ as my regenerative medicine prospects for the future. Both have huge potential, though both obviously come with their own set of risks. Having said this being a medical professional doesn't make me an expert in either company, my area of professional expertise lies outside of these areas.
In addition you don't need to be an expert to know what FDA approval/ rejection will do to any companies share price. Without approvals the company will eventually cease to exist, though In msb's case I think the next 6-9 months holds a few key breakthroughs.
All my own opinion and best of luck to all.
Poll, do we have any medical professionals., page-42
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.045(4.07%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.16 | $1.08 | $4.681M | 4.170M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 99680 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 31000 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |